Healthcare -
Biotechnology - NASDAQ - US
$ 14.13
-4.33 %
$ 1.44 B
Market Cap
-3.95
P/E
DYN - TOTAL CURRENT LIABILITIES
Total Current Liabilities DYN - Dyne Therapeutics, Inc.
51.1 M
LAST VALUE
33.37%
2 YEAR CAGR
135.13%
5 YEAR CAGR
-23.26%
10 YEAR CAGR